Helios-Huaming Biotechnology & Pharmaceuticals Co., Ltd aims to provide new solutions in the treatment of cancers and autoimmune diseases. The company is developing first-in-class inhibitors targeting a novel protein which, as an epigenetic enzyme, plays an essential role in cancer growth and metastasis as well as in multiple autoimmune diseases including Rheumatoid Arthritis, thrombosis, multiple sclerosis, wound healing in diabetes patient etc. Founders of the company includes Dr. Yanming Wang,  Dr. Gong Chen. The founders had worked on the target protein for more than 15 years and their scientific discoveries have been reported by NIH News, Science News etc.